InvestorsHub Logo
Followers 25
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: rjunior79 post# 127899

Saturday, 02/03/2018 10:32:37 PM

Saturday, February 03, 2018 10:32:37 PM

Post# of 203909
Awesome! I appreciate your leg work! If your able to post that or send it to me would be great! Longterm, companies like the one I list below, but many don't really know about, have plenty of powder for buyouts.

. The French pharmaceutical firm Sanofi (NASDAQ: GCVRZ) is one of the companies playing the medical marijuana long-game. As a titan with an epic market cap of almost $124 billion, Sanofi is waiting around to scoop up the cannabis research and development companies once they hit that high. Their current research, involving a wide range of diseases and disorders, focuses on multiple sclerosis and other neurodegenerative diseases which can greatly benefit from cannabinoid-based medicines.